دکتر مهرداد محسنی
پزشک و مدیر در مرکز هماهنگ کننده پژوهش های بالینی پزشکی در سازمان ملی سرطان و مؤسسه بهداشت فدرال آمریکا
Program Director,
National Cancer Institute (NCI), Office of the Director (OD).
Coordinating Center for Clinical Trials (CCCT)
Physician, Harvard Post Graduate
After receiving his M.D. in 1998 and practicing as a physician in the area of general internal medicine, Dr. Mohseni had postdoctoral training in the area of apoptosis; gene polymorphism and hematology-oncology at three different clinical centers affiliated with Harvard Medical School in Boston and investigated the role of regulatory T-cells in chronic graft versus host disease. Dr. Mohseni served as a Scientific Review Officer and managed more than hundred federal study section review panel for 11 years at NIH before joining NCI in 2021.
🇺🇲🇮🇷
Invited by: Ali Khademhosseini
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
July 25, 2023 | 397 | +1 | +0.3% |
November 16, 2022 | 396 | -3 | -0.8% |
July 28, 2022 | 399 | +18 | +4.8% |
June 21, 2022 | 381 | -6 | -1.6% |
May 15, 2022 | 387 | +8 | +2.2% |
April 06, 2022 | 379 | +6 | +1.7% |
February 07, 2022 | 373 | +17 | +4.8% |
January 01, 2022 | 356 | +3 | +0.9% |
November 24, 2021 | 353 | +5 | +1.5% |
October 16, 2021 | 348 | +8 | +2.4% |